Adicet Bio Q3 EPS $(1.16) Misses $(0.74) Estimate
Portfolio Pulse from Benzinga Newsdesk
Adicet Bio (NASDAQ:ACET) reported Q3 losses of $1.16 per share, missing the analyst consensus estimate of $0.74 by 56.76%. This represents a 118.87% increase in losses compared to the same period last year.
November 08, 2023 | 10:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Adicet Bio's Q3 earnings were significantly below analyst expectations, with losses per share increasing by 118.87% compared to the same period last year.
Adicet Bio's Q3 earnings were significantly below analyst expectations, which is likely to negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100